Insulin Delivery

Abbott announced that the FDA has removed the contraindication for its continuous glucose monitoring sensors to be used during imaging procedures.

Medtronic has issued an urgent medical device correction letter warning users of the MiniMed 600 and 700 series of insulin pumps of an increased risk for shorter-than-expected battery life, according to an FDA press release.

There have been many recent regulatory updates in the areas of blood pressure management, dyslipidemia and diabetes management, speakers reported.

Use of AI in medicine is growing quickly. Clinicians are eager to learn what the technology can do, and speakers at meetings across specialties are envisioning its effects — good and bad — in practice management and patient care.

Tandem Diabetes Care emailed notices to users of version 2.7.1 of the Apple iOS t:connect mobile app warning of possible rapid battery depletion of their insulin pump, according to an FDA press release.

Continuous glucose monitors have the potential to alleviate burdens, improve neonatal outcomes and predict disease progression for pregnant women with type 1, type 2 or gestational diabetes, according to two diabetes experts.

ORLANDO — A tubeless automated insulin delivery system improved multiple glycemic outcomes among a large group of adults with type 2 diabetes, according to data presented at the American Diabetes Association Scientific Sessions.

Children exposed to higher levels of certain endocrine-disrupting chemicals in utero were more likely to develop metabolic syndrome than those who were not, according to findings published in JAMA Network Open.

A miniature-sized automated insulin delivery system cleared by the FDA in 2023 is now compatible with a new-generation continuous glucose monitor, according to a press release.

NEW ORLEANS —The rise in use of diabetes medications and continuous glucose monitoring had led to new challenges for treating pregnant women with diabetes.